Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

NCT05099471 is registered in ClinicalTrials.gov with Christian Buske as lead sponsor.

NCT NCT05099471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05099471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
Lead sponsor
Christian Buske
Phase
Phase 2
Overall status
Recruiting
Start date
March 21, 2025
Completion date
March 31, 2033
Enrollment
80 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

treatment naive, waldenstrom macroglobulinemia